Accurate and rapid assessment of sarcopenia in older adults through electrical impedance myography

Ended Project Grant Awarded Last action

Award ID
R44AG074840
Recipient
Awarding agency
Obligated
$5,383,610

Award facts

Assistance listing
93.866 Aging Research
Completion date
Originally
Place of performance
Massachusetts, USA

Award details come from USAspending.gov.

Description

Abstract
This administrative supplement will fund development of regulatory plans in support of commercialization of products and technology developed by parent grant R44AG074840-01A. The parent grant is demonstrating and validating electrical impedance myography (EIM) as a fast, painless, inexpensive, non-intrusive, accurate method for the assessment of lower extremity muscle condition in older adults. In the parent grant, we are establishing EIM, via its new device, the mscan®, in conjunction with machine learning cloud-based platform, as a means of obtaining MRI-like quantitative data in muscle of older adults. With the support of this administrative supplement, we plan to achieve DE novo authorization for marketing from the FDA for the mscan device and the supporting platform.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $813,035
Amendment $813,035
Amendment $50,000
Amendment $50,000
Amendment $50,000
Amendment $50,000
Amendment $889,385
Amendment $889,385
Amendment $889,385
Original award $889,385
Show all 12

Quick answers

Who received award R44AG074840?

R44AG074840 was awarded to Myolex, Inc. by National Institute on Aging (National Institutes of Health) on August 1, 2022.

How much is award R44AG074840 worth?

$5,383,610 has been obligated on R44AG074840.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award